NCT04147572View on ClinicalTrials.gov

Inspiratory Flow Parameters With Placebo Easyhaler and Placebo HandiHaler

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

January 13, 2020

Study Completion Date

January 13, 2020

Conditions
Healthy VolunteerCOPD
Interventions
DRUG

Placebo Tiotropium inhalation powder type A

Placebo inhalation from inhaler A

DRUG

Placebo Spiriva capsule

Placebo inhalation from HandiHaler

DRUG

Placebo Tiotropium inhalation powder type B

Placebo inhalation from inhaler B

DEVICE

Substudy Placebo Tiotropium Easyhaler

Substudy placebo inhalation

DEVICE

Substudy Placebo Spiriva® via HandiHaler

Substudy placebo inhalation

Trial Locations (1)

Unknown

Lung Clinic, Tartu University Hospital, Tartu

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT04147572 - Inspiratory Flow Parameters With Placebo Easyhaler and Placebo HandiHaler | Biotech Hunter | Biotech Hunter